American Regent, Inc. recalls Epinephrine Injection
- Published
- 16 Sept 2026
- Units affected
- 31,935 30mL-vials
- Agency
- FDA
- Country
- United States
The hazard
Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01
- Brand / company
- American Regent, Inc.
- Codes / lots
- Lots: 25128L1C0, Exp. August 31, 2026; 25280L1C0, Exp. October 31, 2026; 26108L1C0, Exp. July 31, 2027
- Distribution
- Nationwide within the U.S.A
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 16 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.